Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

Novel adjuvants present a concern for adverse effects, generating a need for alternatives. Rotavirus inner capsid VP6 protein could be considered a potential candidate, due to its ability to self-assemble into highly immunogenic nanospheres and nanotubes. These nanostructures exhibit immunostimulato...

Full description

Bibliographic Details
Main Authors: Suvi Heinimäki, Kirsi Tamminen, Vesa P. Hytönen, Maria Malm, Vesna Blazevic
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Vaccines
Subjects:
VP6
Online Access:https://www.mdpi.com/2076-393X/8/3/365

Similar Items